Abstract:Introduction: Cannabis use is known to be associated with significant cardiovascular morbidity. We describe three cases of cannabis-related malignant arrhythmias, who presented to the cardiac department at our institution within the last 2 years. All three patients were known to smoke cannabis on daily basis. Case summaries: Case 1: A 30-year-old male, presented with recent onset of palpitations. A 12-lead electrocardiogram (ECG), transthoracic echocardiogram (TTE), and blood tests were all normal. During an inpatient exercise treadmill test (ETT) he developed polymorphic ventricular tachycardia (VT), which converted spontaneously to supraventricular tachycardia (SVT) in the recovery phase of the test. Subsequent risk stratification with cardiac magnetic resonance imaging and coronary angiography showed no abnormalities and an electrophysiological study was negative for sustained VT, however, SVT was easily induced with rapid conversion to atrial fibrillation. The patient successfully stopped smoking all tobacco products including cannabis and was treated with beta-blockers, with no further episodes of arrhythmia. Case 2: A 30-year-old male presented to the Emergency Department with palpitations, chest pain, and dizziness that improved during exertion. His initial ECG demonstrated complete atrioventricular block (AVB). Subsequent traces showed Mobitz Type I and second-degree AVB, which converted to atrial flutter after exertion. Routine blood tests, TTE, and an ETT were all normal and he was discharged home with no conduction abnormalities. Case 3: A 24-year-old male presented with two episodes of syncope. Baseline examination was normal, with an ECG showing a low atrial rhythm. Interrogation of his implantable loop recorder showed episodes of early morning bradycardia episodes with no associated symptoms. Discussion: Cannabis-related arrhythmia can be multiform regarding their presentation. Therefore, ambiguous combinations of arrhythmia should raise suspicion of underlying cannabis abuse, where clinically appropriate. Although causality with regards to cannabis use cannot be proven definitively in these cases, the temporal relationship between drug use and the onset of symptoms suggests a strong association.

Cannabinoids and the heart—a psychiatrist's perspective

Effects of cannabis use on the heart

Cannabis, cannabinoids and health: a review of evidence on risks and medical benefits

Reevaluating America's Latest Pharmaceutical Trend: The Cardiovascular Risk of Cannabis

Positive and Negative Effects of Cannabis and Cannabinoids on Health

The pharmacokinetics and the pharmacodynamics of cannabinoids.

Dissecting the role of cannabinoids in vascular health and disease

Potential perioperative cardiovascular outcomes in cannabis/cannabinoid users. A call for caution

Pharmacology of Non-Psychoactive Phytocannabinoids and Their Potential for Treatment of Cardiometabolic Disease

Cannabis for chronic pain: cardiovascular safety in a nationwide Danish study

[Cannabis use and cannabis use disorders]

Cannabis use and cardiovascular diseases

The Impact of Marijuana on the Cardiovascular System: A Review of the Most Common Cardiovascular Events Associated with Marijuana Use

Cannabis und kardiovaskuläre Risiken

Targeting cannabinoid receptor CB2 in cardiovascular disorders: promises and controversies

Why Do Marijuana and Synthetic Cannabimimetics Induce Acute Myocardial Infarction in Healthy Young People?

Cannabis induced cardiac arrhythmias: a case series

The Heart and Cannabis (THC) Cohort: Differences in Baseline Health and Behaviors by Cannabis Use

A critical assessment of the abuse, dependence and associated safety risks of naturally occurring and synthetic cannabinoids

Cannabis, 1977

Neurological Complications of Cannabinoids